Atlas Trials

Second-line FOLFOX With or Without Regorafenib in mCRC Patients Failed to First-line Irinotecan Plus Fluoropyrimidines

Clinical trial NCT01786538 · WITHDRAWN

Trial details

NCT number
NCT01786538
Sponsor
Asan Medical Center
Status
WITHDRAWN
Phase
Phase 3
Study type
INTERVENTIONAL
Metastatic Colorectal Cancer
Start date
2013-06-01
Primary completion
2016-05-01
Enrollment
0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.